retatrutide obesity treatment 🚨 HOT OFF THE PRESS: Phase 3 data has arrived — and the medicine world is paying attention. In Lilly's TRIUMPH-1 trial, participants receiving the highest dose achieved an average Retatrutide Severe Obesity Trial Shows

Research shows that people who prioritize protein and fiber often experience weight loss and have lower body weights

The relative risks of incident microvascular events showed subgroup variations, with SGLT2i being associated with a decreased risk than GLP1-RA among those expected to gain glycemic benefits with SGLT2 inhibitors

Haematogenous spread is spread of melanoma cells in the bloodstream, which can happen either by a tumour invading blood vessels or secondary to lymph node involvement

It's approved for short-term use (a few weeks) only

5 mg of tirzepatide equals 50 units at a concentration of 10 mg/mL, or 25 units at a concentration of 20 mg/mL

Clinicians usually start GLP-1s at a low dose to avoid nausea and other side effects, then slowly increase the dose every 1 to 4 weeks based on your tolerance and blood sugar response